Genetec Corp. (4492) AI Stock Analysis

• Market Cap: ¥5.47B
• Dividend Yield: 3.71%
• Average Volume (3M): 20.16K
• Price to Earnings (P/E): 14.0
• Beta (1Y): 0.85
• Revenue Growth: 11.30%
• EPS Growth: -21.37%
• Country: JP
• Employees: 347
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 1.50
• Shares Outstanding: 11,727,700
• 10 Day Avg. Volume: 14,300
• 30 Day Avg. Volume: 20,160
• PEG Ratio: 14.41
• Price to Book (P/B): 2.49
• Price to Sales (P/S): 0.74
• P/FCF Ratio: 15.58
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥546.00
• Price Target Upside: 15.68% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 73 Outperform
• Price Target: ¥546.00 ▲(15.68% Upside)

Genetec Corp. benefits from strong financial performance and attractive valuation, which are the primary drivers of its stock score. However, technical indicators suggest bearish momentum, which tempers the overall score.

Genetec Corp. Business Overview & Revenue Model

Company Description

Genetec Corp. (4492) is a leading technology company specializing in advanced security solutions. It operates primarily in the security and surveillance sector, providing innovative software and hardware products designed for physical security and operations management. The company's core offerings include video surveillance systems, access control solutions, and license plate recognition technologies, all aimed at enhancing safety and security for various organizations, including government entities, transportation systems, and private enterprises.

How the Company Makes Money

Genetec Corp. generates revenue primarily through the sale of its software and hardware products, which include video management systems, access control systems, and integrated security platforms. The company employs a subscription-based model for many of its software solutions, allowing customers to access ongoing updates and support. Additionally, Genetec earns income from licensing its technology and providing maintenance and support services. Key revenue streams include direct sales to customers, recurring subscription fees, and partnerships with resellers and integrators that expand its market reach. Strategic alliances with hardware manufacturers and collaborations with industry leaders also contribute to its revenue, enabling Genetec to deliver comprehensive security solutions tailored to diverse customer needs.

Genetec Corp. Financial Statement Overview

Summary

Genetec Corp. demonstrates strong revenue growth and profitability, supported by a solid balance sheet with low leverage and effective equity utilization. Cash flow management shows room for improvement, but overall financial health is robust.

Income Statement

Genetec Corp. demonstrates healthy revenue growth, with a notable increase from 2024 to 2025. The gross profit margin is strong at approximately 40%, indicating good cost control relative to revenue. Net profit margin is also healthy at around 5%, showing profitability. However, the EBIT margin is moderate, suggesting room for operational efficiency improvements.

Balance Sheet

The company has a relatively low debt-to-equity ratio, indicating low financial leverage, which is favorable. The return on equity (ROE) is robust, reflecting efficient use of shareholder capital. The equity ratio is stable, suggesting a strong capital base and financial stability.

Cash Flow

Genetec Corp. has shown fluctuations in free cash flow but maintains a positive trajectory. The operating cash flow to net income ratio is positive, indicating efficient cash generation from operations. However, there is room for improvement in free cash flow management.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	8.60B	8.12B	7.15B	5.86B	4.68B	4.08B
Gross Profit	3.37B	3.27B	2.91B	2.32B	1.96B	1.56B
EBITDA	748.79M	829.40M	783.24M	245.09M	153.83M	301.93M
Net Income	385.60M	421.12M	414.77M	23.76M	56.64M	173.41M
Balance Sheet
Total Assets	6.80B	7.15B	4.52B	4.12B	3.25B	2.84B
Cash, Cash Equivalents and Short-Term Investments	1.92B	1.99B	1.17B	1.08B	1.04B	1.48B
Total Debt	2.28B	2.26B	640.00M	976.09M	50.62M	75.00M
Total Liabilities	4.49B	4.75B	2.31B	2.26B	1.39B	1.02B
Stockholders Equity	2.31B	2.40B	2.21B	1.87B	1.86B	1.83B
Cash Flow
Free Cash Flow	0.00	384.76M	495.19M	-359.44M	-176.37M	406.28M
Operating Cash Flow	0.00	451.42M	602.37M	-223.12M	-24.03M	443.26M
Investing Cash Flow	0.00	-388.73M	-55.73M	-439.20M	-98.15M	-38.53M
Financing Cash Flow	0.00	655.92M	-410.02M	714.93M	-94.71M	-76.04M

Genetec Corp. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 472.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4492, the sentiment is Negative. The current price of 472 is below the 20-day moving average (MA) of 485.60, below the 50-day MA of 484.60, and below the 200-day MA of 489.05, indicating a bearish trend. The MACD of -2.56 indicates Positive momentum. The RSI at 43.38 is Neutral, neither overbought nor oversold. The STOCH value of 38.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4492.

Genetec Corp. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4060	77 Outperform	¥6.91B	23.00	―	0.52%	10.95%	39.53%
3841	77 Outperform	¥5.19B	24.76	―	2.99%	2.53%	-32.88%
4492	73 Outperform	¥5.47B	14.03	―	3.71%	11.30%	-21.37%
4491	69 Neutral	¥5.20B	12.93	―	1.96%	6.83%	17.32%
4829	66 Neutral	¥4.24B	175.08	―	2.73%	-4.90%	-85.89%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
2321	47 Neutral	¥9.77B	―	―	―	-1.68%	85.30%